Individual proteins can now often be modified with atomic precision, but there are still major obstacles to connecting proteins into larger assemblies. To direct protein assembly, ideally, peptide tags would be used, providing the minimal perturbation to protein function. However, binding to peptides is generally weak, so assemblies are unstable over time and disassemble with force or harsh conditions. We have recently developed an irreversible protein-peptide interaction (SpyTag/SpyCatcher), based on a protein domain from Streptococcus pyogenes, that locks itself together via spontaneous isopeptide bond formation. Here we develop irreversible peptide-peptide interaction, through redesign of this domain and genetic dissection into three parts: a protein domain termed SpyLigase, which now ligates two peptide tags to each other. All components expressed efficiently in Escherichia coli and peptide tags were reactive at the N terminus, at the C terminus, or at internal sites. Peptide-peptide ligation enabled covalent and site-specific polymerization of affibodies or antibodies against the tumor markers epidermal growth factor receptor (EGFR) and HER2. Magnetic capture of circulating tumor cells (CTCs) is one of the most promising approaches to improve cancer prognosis and management, but CTC capture is limited by inefficient recovery of cells expressing low levels of tumor antigen. SpyLigase-assembled protein polymers made possible the isolation of cancerous cells expressing lower levels of tumor antigen and should have general application in enhancing molecular capture.
Individual proteins can now often be modified with atomic precision, but there are still major obstacles to connecting proteins into larger assemblies. To direct protein assembly, ideally, peptide tags would be used, providing the minimal perturbation to protein function. However, binding to peptides is generally weak, so assemblies are unstable over time and disassemble with force or harsh conditions. We have recently developed an irreversible protein-peptide interaction (SpyTag/SpyCatcher), based on a protein domain from Streptococcus pyogenes, that locks itself together via spontaneous isopeptide bond formation. Here we develop irreversible peptide-peptide interaction, through redesign of this domain and genetic dissection into three parts: a protein domain termed SpyLigase, which now ligates two peptide tags to each other. All components expressed efficiently in Escherichia coli and peptide tags were reactive at the N terminus, at the C terminus, or at internal sites. Peptide-peptide ligation enabled covalent and site-specific polymerization of affibodies or antibodies against the tumor markers epidermal growth factor receptor (EGFR) and HER2. Magnetic capture of circulating tumor cells (CTCs) is one of the most promising approaches to improve cancer prognosis and management, but CTC capture is limited by inefficient recovery of cells expressing low levels of tumor antigen. SpyLigase-assembled protein polymers made possible the isolation of cancerous cells expressing lower levels of tumor antigen and should have general application in enhancing molecular capture.
bionanotechnology | synthetic biology | metastasis | antibody | nanobiotechnology P eptide tags are powerful tools for analyzing protein function, but have major limitations for controlling protein function (1, 2) . The flexibility and small surface area of peptides mean that peptide interactions are typically weak and reversible (3) , and generally depend on binding of large protein partners (4-6). These restrictions limit how peptides can be used for nanoassembly and synthetic biology (7) (8) (9) . We sought to develop irreversible covalent interaction between two peptides; we desired all parts to be genetically encoded, with no cysteines involved, and with flexibility in location of the peptide tags. Covalent reaction would enable peptide interactions to resist force, as the strongest noncovalent interactions can be broken by molecular motors (10) or by the forces acting during cell isolation (11) .
CnaB2 is a domain from the fibronectin adhesion protein FbaB of Streptococcus pyogenes (Spy), essential for the bacteria to invade human cells (12) . Within CnaB2, there is a spontaneous reaction to form an isopeptide bond between Lys and Asp, catalyzed by an apposed Glu (Fig. 1A) (13, 14) . We previously showed that the CnaB2 domain could be split into two parts to enable protein-peptide ligation, via isopeptide bond formation between a peptide tag (i.e., SpyTag) and a protein domain (i.e., SpyCatcher) (15) . Here we establish how CnaB2 can be split into three parts to enable peptide-peptide ligation.
We applied peptide-peptide ligation to address a major challenge in cell isolation. Isolation of rare cells has applications in stem cell therapy (16) , adoptive immunotherapy (17) , and the capture of circulating tumor cells (CTCs). Analyzing CTCs is one of the most promising ways to improve cancer prognosis and to personalize therapy according to the expression pattern of each individual's cancer (18) . CTC isolation is a great challenge because of the low frequency of CTCs (one CTC in 10 6 -10 9 normal leukocytes) and the heterogeneous antigen expression of CTCs (18) . The difficulty of capturing CTCs expressing low levels of tumor marker is an important limiting factor, leading to a high frequency of false-negative results in CTC testing (18, 19) . We previously showed that isolation of low-expressing cells depends on ultrastable interactions between the binding protein and the magnetic bead, as well as formation of a large number of contacts at the bead:cell synapse (11) . Magnetic cell capture is typically performed with beads bearing a monolayer of binding protein (11, 18, 19) . We hypothesized that forming extended chains of the antigen-binding protein would enable the bead to encounter more copies of the tumor antigen, thus reducing the expression level required for cell recovery. Also, because any weak link impairs recovery (11) , it is essential that the binding proteins are linked together through irreversible covalent bonds. Therefore, we explored the creation of SpyLigase-assembled protein polymers to enable capture of low-expressing cancer cells.
Results
Design of SpyLigase. SpyTag (13 aa) was left unchanged (15) but the β-strand of CnaB2 containing the reactive Lys was separately expressed and termed KTag (10 aa; Fig. 1B ). SpyLigase (11 kDa) was derived from SpyCatcher by (i) removing residues from the β-strand containing the reactive Lys and (ii) circular permutation, replacing residues from the C terminus of CnaB2 with a Gly/Ser linker followed by N-terminal CnaB2 residues ( Fig. 1B ; amino acid sequence in Fig. S1 ). We hypothesized that SpyTag Significance Building proteins into assemblies faces challenges in specificity and stability of the connections. Proteins are ideally connected via peptide tags for minimal disruption of function. Streptococcus pyogenes contains a protein that locks itself together. After genetic dissection, we created a protein (SpyLigase) that locks two peptide tags together. With tags on opposite ends of an antibody or affibody (an antibody-like scaffold), SpyLigase assembled the proteins into polyantibody or polyaffibody chains. Magnetic beads can isolate specific cell types, but the small area of bead-to-cell contact means that abundant cellspecific target is required for cell capture. Polymerization of affibodies enabled capture of cancerous cells expressing less cancer marker and should enhance sensitivity of cell isolation for various research and clinical applications.
and KTag would dock with SpyLigase and the triad would be optimally arranged as in CnaB2 to direct covalent ligation of SpyTag with KTag.
SpyLigase Enabled Peptide-Peptide Ligation. KTag fused at the C terminus of small ubiquitin modifier from Saccharomyces cerevisiae (SUMO; i.e., SUMO-KTag) and SpyLigase were well expressed in Escherichia coli and were soluble at >200 μM (SUMO-KTag) or >800 μM (SpyLigase), with no apparent precipitation upon storage for weeks at 4°C. We incubated SUMO-KTag with SpyTag fused at the N terminus of maltose binding protein (MBP; i.e., SpyTag-MBP) in the presence of SpyLigase: a new product was generated, stable to boiling in SDS, and with a mobility consistent with isopeptide bond formation between SpyTag and KTag (Fig.  1C) . With only two of the three components present, with mutation of Glu 77 to Gln in SpyLigase (i.e., SpyLigase EQ), or with mutation of the reactive Asp in SpyTag (i.e., SpyTag DA-MBP), there was no reaction (Fig. 1C) .
Dependence of Ligation on Conditions. To explore the generality of the SpyLigase reaction, we added SpyTag and KTag to different termini. SpyLigase was able to drive reaction between SpyTag and KTag at the N terminus or C terminus ( Fig. 2A) . SpyLigase also directed KTag ligation to SpyTag inserted in the middle of a protein (i.e., MBP-SpyTag-Zif-SpyTag, containing SpyTag between MBP and the Zif268 zinc fingers; Fig. 2B ). We examined the dependence of SpyLigase reaction on temperature: 4°C gave the highest yield, which gradually decreased as the temperature increased to 37°C (Fig. 2C ). The temperature dependence was also studied by CD, showing a change in secondary structure for SpyLigase as temperature was increased from 4°C to 37°C (Fig. S2A) . Usually, proteins show a sharp transition at the melting point by CD as the temperature is increased, but the change was gradual for SpyLigase (Fig. S2B) , consistent with SpyLigase having a dynamic structure (20) .
We confirmed the nature of the covalent reaction between SpyTag and KTag by electrospray-ionization MS. The molecular weight of the SUMO-SpyTag:SUMO-KTag adduct matched the sum of the individual masses (SUMO-SpyTag 13,974 Da; SUMOKTag 13,703 Da) minus the mass of water, consistent with isopeptide bond formation (Fig. 2D) .
Generation of Protein Polymers by Using SpyLigase. We used SpyLigase to polymerize affibodies to create multivalent chains for sensitive cell capture. Affibodies are a nonimmunoglobulin scaffold, consisting of a three-helix bundle, selected for high-affinity binding through phage display, and easily expressed in E. coli (21) . The initial affibody we modified bound strongly and specifically to epidermal growth factor receptor (EGFR) (21), a tyrosine kinase expressed on many cancer cells and a target antigen in CTC isolation (22, 23) . We inserted KTag at the N terminus of the affibody and SpyTag at the C terminus (i.e., KTag-AffiEGFRSpyTag) so that covalent ligation between KTag and SpyTag would generate chains (Fig. 3A) . Locating the tags at opposite ends was designed to inhibit cyclization. Mixing KTag-AffiEGFR-SpyTag with SpyLigase efficiently generated affibody polymers resistant to boiling in SDS (Fig. 3B) . No polymers formed with the nonreactive SpyLigase EQ (Fig. 3B) .
To demonstrate the generality of this SpyLigase approach, we tested a second affibody, binding with high affinity to HER2 (an important tyrosine kinase cancer antigen, also known as ErbB2 or Neu) (23, 24) . KTag-AffiHER2-SpyTag was similarly polymerized by SpyLigase, forming high molecular weight species extending to more than 20 affibody units (Fig. 3C) . A Fab antibody fragment against HER2, bearing SpyTag at the N terminus of the heavy chain and KTag at the C terminus of the light chain, was efficiently expressed in mammalian cells. SpyTag-Fab-KTag was also linked by SpyLigase to generate covalently assembled antibody multimers (Fig. S3 ).
Affibody Polymers Enhanced Magnetic Cell Capture. We applied KTag-AffiEGFR-SpyTag polymers to enhance the recovery of low antigen-expressing cells for magnetic cancer cell isolation ( Fig. 4A) (11, 19) . Because all of the polymers terminate with a SpyTag, the polymers can be covalently anchored with precise orientation on beads coated with SpyCatcher (15) . SpyCatcher itself was linked to the 2.8-μm-diameter beads via a disulfide, so boiling with DTT revealed the affibody polymers attached to the beads (Fig. S4 ). For the monomeric beads, samples were treated identically to the polymeric beads except the inactive SpyLigase EQ control was used instead of SpyLigase; therefore, a single affibody could attach to each SpyCatcher on the bead but there would not be formation of polymers.
To evaluate the effect of polymerization on cell capture, we studied a panel of cancer cell lines bearing a range of EGFR expression levels: MDA-MB-468 cells express high levels, BT474 cells express low levels, and 771.221 cells do not express detectable levels, as confirmed by flow cytometry (Fig. 4A ). Monomeric and polymeric beads were incubated with each cell type for 20 min. After magnetic isolation, the efficiency of cell recovery was determined by Coulter counting. Capture by monomeric beads was efficient for the highest expressing cells but recovery was significantly improved with polymeric beads (n = 3; P = 0.03, unpaired t test; Fig. 4B ). Beads coated with monomeric affibody could not capture the low-expressing BT474 cells: monomeric beads did not give capture significantly above the background recovery of the nonexpressing 721.221 cells (n = 3; P = 0.09, not significant, unpaired t test; Fig. 4C ). However, recovery of BT474 was greatly improved by using polymeric beads (n = 3; P < 0.0001, unpaired t test; Fig. 4C ). The use of polymeric beads did not change specificity, as background recovery of 721.221 cells was equivalent for monomeric and polymeric beads (n = 3; P = 0.97, not significant, unpaired t test; Fig. 4C ).
We previously showed that cell capture sensitivity was greatly improved by acute loading of cells with cholesterol, an important modulator of membrane dynamics and flexibility (11) . Cholesterol loading enhanced the recovery of BT474 by using polymeric beads (n = 3; P = 0.01, unpaired t test) but did not improve recovery with monomeric beads (Fig. S5) .
As a further test of affibody polymer efficacy, we generated polymers of an affibody against HER2 by using SpyLigase; when testing recovery of cells doped into a blood sample, polymeric beads gave a highly significant increase in recovery of the high HER2-expressing BT474 (n = 3; P = 0.0005, unpaired t test) as well as the low HER2-expressing MCF-7 cells (n = 3; P = 0.0001, unpaired t test; Fig. S6 ) (11) . Polymeric beads did not reduce specificity, as tested by counting recovery of the HER2-negative 721.221 cells, or by fluorescence microscopy showing that recovered cells were carboxyfluorescein succinimidyl ester-positive and negative for CD45, a surface protein common to leukocytes (Fig. S6) .
Discussion
There are many examples of proteins split into two that have restored function when the parts reconstitute, including split fluorescent proteins, proteases, and luciferase (25). There are much fewer precedents for splitting a protein into three (26-28).
Here we have generated a three-part protein, with a protein domain bringing together and driving reaction between two distinct peptide tags. We have demonstrated here this ligation for SpyTag in six different protein contexts. SpyLigase represents a principle for peptide-peptide ligation not yet found in nature.
Various elegant approaches have been devised to target fluorophores or other small molecules covalently to either peptides (e.g., with FlAsH or Sfp phosphopantetheinyl transferase) or to ≥20 kDa proteins (e.g., HaloTag and SNAP-tag) (29), but there are few ways to achieve covalent reaction between two genetically encoded peptides. Natural enzymes have been harnessed for peptide ligation, such as transglutaminase, but this enzyme tends to react promiscuously (30). Cys-bearing peptides can associate noncovalently and then form a disulfide, e.g., "dock-and-lock" (31), but adding a new Cys can interfere with folding of existing disulfides. Subtiligase can direct amide bond formation but substrates require an ester-activated C terminus, and its great advantage for proteomics is that almost any N-terminal sequence is reactive (32, 33). Native chemical ligation also allows reaction by using a strategically placed cysteine residue, but, like split inteins and sortase, is limited to the N-and C-termini for fusion of the proteins (34-36), disallowing nonlinear protein architectures. Therefore, SpyLigase, with no cysteine-bearing components and the ability to direct isopeptide bond formation to an internal peptide tag, possesses unique characteristics for protein modification and assembly, although it will be valuable in the future to evolve SpyLigase and its peptide partners for greater speed and yield.
A range of innovative approaches have been taken to enhance CTC capture, including microvortex-generating herringbone chips (37) and microfluidic devices enabling capture of lower expressing cells (38), although magnetic separation has advantages over microfluidics in terms of simplicity and throughput (18, 19) . Poly(amidoamine) dendrimers and silicon nanowires have previously given a nanostructured surface enhancing cancer cell capture (39, 40). Polymeric "tentacles" of DNA aptamers also showed promise for rare cell isolation (41). Here we have shown the functional advantage of covalent protein polymerization for capture of cells. Multivalency is a powerful way to enhance biological function and with the right ligand organization gives dramatic improvements in affinity, kinetics and specificity (42, 43). The multivalency of the SpyLigase-assembled affibody polymers enhanced the capture of cancerous cells expressing low levels of tumor antigen, without loss of specificity. Moving protein binders from 2D into 3D via isopeptide-linked protein chains extending from surfaces has potential to enhance detection in a wide variety of areas, including immunoassays, microfluidic cell isolation, and detection of pathogens by nanoparticles (44).
Materials and Methods
In Vitro Reconstitution. SI Materials and Methods provides a full description of cloning, protein expression and purification, MS, CD, culture of cell lines, coupling of SpyCatcher to beads, beading from human blood, flow cytometry, and statistical analysis. Briefly, all proteins were expressed in E. coli, except for Fab produced in HEK 293T cells, and were purified via Ni-NTA resin.
To test SpyLigase reaction, 10 μM SpyTag-MBP or SpyTag DA-MBP and 10 μM SUMO-KTag were incubated for 24 h at 4°C with 40 μM SpyLigase or SpyLigase EQ in PCT buffer: 40 mM Na 2 HPO 4 and 20 mM citric acid buffer, pH 5.0, with addition of 1.5 M trimethylamine N-oxide (TMAO; SigmaAldrich) to give final pH 7.0. TMAO is a chemical chaperone (45). To test the Affibody and Antibody Polymerization. A total of 100 μM SpyLigase (EQ) was incubated with 38 μM KTag-AffiEGFR-SpyTag for 24 h at 4°C in 40 mM Na 2 HPO 4 , 20 mM citric acid, 1 M TMAO, pH 6.8. A small amount of a second band corresponding to twice the molecular weight of KTag-AffiEGFR-SpyTag was seen (Fig. 3B) , which is most likely from double reaction of (KTagAffiEGFR-SpyTag) 2 . A total of 76 μM KTag-AffiHER2-SpyTag was incubated with 200 μM SpyLigase (EQ) for 48 h at 4°C in PCT buffer. A total of 150 μM SpyLigase (EQ) was incubated with 50 μM SpyTag-Fab-KTag for 24 h at 4°C in PCT buffer.
Coupling of Affibodies for Polymerization on Beads. SpyCatcher beads were washed thrice with PBS solution, then 8.3 μM KTag-AffiEGFR-SpyTag or KTagAffiHER2b-SpyTag was added to beads and incubated for 2 h at 25°C with 1,200 rpm shaking on a ThermoMixer comfort (Eppendorf). After incubation, beads were placed on the magnet and uncoupled affibody removed. Beads were split into two vials and washed three times with PBS solution. For polymerization, beads were resuspended in PCT buffer and affibody was added to 76 μM. To polymerize affibody on beads, SpyLigase at a final concentration of 200 μM was added (polymeric beads); for monomeric beads, 200 μM SpyLigase EQ was added. Beads were incubated on a ThermoMixer for 72 h at 4°C with 1,200 rpm shaking. Polymerization was assessed by SDS/PAGE after boiling in SDS-loading buffer containing 100 mM DTT.
Immunomagnetic Isolation. Immunomagnetic isolation of cells with polymeric and monomeric beads was carried out as previously described (11) . Briefly, MDA-MB-468, BT474, and 721.221 cells were harvested and resuspended at 2.5 × 10 6 cells per milliliter in DMEM with 1% FCS, 50 U/mL penicillin, and 50 μg/mL streptomycin (D1). A total of 100 μL of cells were used per condition. Cells were incubated for 1 h at 25°C in D1 with 250 μg/mL water-soluble cholesterol (Sigma-Aldrich; rendered water-soluble through the presence of methyl-β-cyclodextrin; cholesterol was withheld in Fig. S5 ). Then, 12.5 μL monomeric or polymeric beads (based on 2.8-μm diameter DynaBeads), previously washed three times with PBS solution and once with D1, were added to cells, and the volume was adjusted to 500 μL with D1. Cell/bead mixtures were incubated at 25°C for 20 min with end-over-end rotation. A total of 100 μL of the cell/bead mixture was then pipetted out for counting. The remaining cells were placed onto a magnet. Cells bound to magnetic beads were washed with 500 μL D1 and placed on a ThermoMixer for 30 s at 25°C with 1,100 rpm shaking. Cells bound to beads were then resuspended in 100 μL D1. Cells were counted on a Coulter Counter (CasyR Model TT; Innovatis) using a 150-μm measuring capillary, with 400 μL sample volume and evaluation cursor of 7.5-50 μm. Percent recovery was calculated as 100 × (number of recovered cells / number of cells originally present). culture were 7 mg for SUMO fusions, 16 mg for MBP fusions, and 20 mg for SpyLigase.
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Protein Expression and Purification from Mammalian Cells. SpyTagFab-KTag was expressed in HEK 293T cells grown in roller bottles (Greiner) in 250 mL DMEM with 10% (vol/vol) FCS, 50 U/mL penicillin, and 50 μg/mL streptomycin. HEK 293T cells were transfected in serum-free DMEM with 50 U/mL penicillin and 50 μg/mL streptomycin, using 1.15 mg polyethyleneimine (25 kDa; Sigma) with 160 μg heavy-chain plasmid and 160 μg lightchain plasmid. These plasmids were endotoxin-free, prepared using the Fisher Maxiprep kit. A total of 25 mM Hepes, 3.8 mM valproic acid (Sigma), and 4 mM glutamine (Life Technologies) were added at transfection. Four days following transfection, the supernatant was harvested using centrifugation at 4,000 × g for 20 min at 4°C. A total of 25 mL 10× PBS and MgCl 2 to a final concentration of 100 μM were added to the supernatant. Fab was purified by using standard methods on Ni-NTA, as described previously (13), and dialyzed three times in a 1,000-fold excess of PBS solution for at least 3 h each time at 4°C. Protein concentration was determined from OD 280 with the extinction coefficient from ExPASy ProtParam. Typical yield was 6 mg per liter of culture.
MS. A total of 10 μM SUMO-KTag, 10 μM SUMO-SpyTag, and 40 μM SpyLigase were incubated for 24 h in 40 mM Na 2 HPO 4 and 20 mM citric acid buffer, pH 5.0, with addition of 1.5 M trimethylamine N-oxide (Sigma-Aldrich) to give final pH 7.0 (PCT buffer) at 4°C. The samples were spin-filtered to enrich the SUMO-KTag:SUMO-SpyTag adduct using a Vivaspin 30,000 molecular weight cutoff column (Sartorius). Before analysis, the protein samples were extracted with a C4 ZipTip (Millipore). MS was performed in positive ion mode in 50% (vol/vol) acetonitrile/ water, 0.1% formic acid, using a Micromass LCT time-of-flight electrospray ionization MS (Micromass). MassLynx V4.00.00 software (Waters) converted the m/z spectrum to molecular mass by using a maximum entropy algorithm. ExPASy ProtParam predicted mass based on the sequence, with the N-terminal fMet residues cleaved.
CD. Far-UV CD spectra of SpyLigase were recorded by using a Jasco J-815 spectropolarimeter. Samples were analyzed in 0.5-mm path-length quartz cuvettes at 0.5 mg/mL in PCT buffer. Far-UV spectra were recorded between 205 and 260 nm at 4, 12, 25, and 37°C and data were collected at 0.2-nm intervals. Three scans were recorded, averaged for each spectrum, and smoothed with a Savitzky-Golay filter (14) by using Jasco J-815 Spectra Manager software. The temperature-dependent profile of SpyLigase was recorded between 215 and 250 nm, ramping from 4°C to 90°C at 2°C/min.
Culture of Cell Lines. MDA-MB-468 cells (human breast cancer cell line) were from American Type Culture Collection, and BT474 and MCF-7 (human breast cancer cell-lines) were from Cancer Research UK at Lincoln's Inn Fields, and LBL 721.221 cells (human lymphoblastoid cell line) were a gift from Tim Elliott (University of Southampton, Southampton, United Kingdom). Cells were grown in DMEM with 10% (vol/vol) FCS, 50 U/mL penicillin, and 50 μg/mL streptomycin. Insulin (Sigma-Aldrich) was added to BT474 cells at 5 μg/mL. All cells were passaged for fewer than 6 mo. For Mycoplasma testing, 1 mL cell culture supernatant from each cell line in a 1.5-mL microcentrifuge tube was spun for 3 min at 1,700 × g to pellet cellular debris. The obtained supernatant was transferred to a new tube and spun for 10 min at 17,000 × g to sediment Mycoplasma. The supernatant was decanted and the pellet (not visible) was resuspended with 50 μL MilliQ water and mixed thoroughly. Samples were heated for 3 min at 95°C and then Mycoplasma presence was assessed by PCR by using 5′-GGGAGCAAACAGGATTAGATAC-CCT and 5′-TGCACCATCTGTCACTCTGTTAACCTC with Taq DNA Polymerase (NEB). Samples were heated at 94°C for 0.5 min and then processed for 35 cycles heating at 94°C for 2 min, 60°C for 2 min, and 72°C for 1 min. Samples were finally heated for one cycle at 94°C for 0.5 min, 60°C for 2 min, and 72°C for 5 min. The positive control was the PCR template from the EZ-PCR Mycoplasma test (Biological Industries). Amplified products were detected by loading onto an ethidium bromide-stained 2% (wt/vol) agarose gel, imaged under UV by a ChemiDoc XRS+ Imager. The cell lines tested negative for Mycoplasma.
Coupling of Cys-SpyCatcher to Beads. Dynabeads M-270 Amine (2.8-μm diameter superparamagnetic polystyrene beads with primary amino functionalities on their surface, 2 × 10 9 beads per milliliter; Life Technologies) were washed thrice with PBS solution with 0.1 M NaHCO 3 , pH 8.0 (coupling buffer). A solution of sulfosuccinimidyl 6-(3′-[2-pyridyldithio]-propionamido)hexanoate (Thermo Scientific) was added to beads at a final concentration of 2.5 mM and incubated on a ThermoMixer for 1 h at 25°C with 1,000 rpm shaking. Beads were then placed onto a magnet (MagRack 6, GE Healthcare) and excess sulfosuccinimidyl 6-(3′-[2-pyridyldithio]-propionamido)hexanoate removed. After washing beads thrice with PBS solution, beads were resuspended at 2 × 10 9 beads per milliliter in 200 μM Cys-SpyCatcher, for disulfide-mediated attachment for 16 h at 25°C with 1,000 rpm shaking. Beads were washed thrice with PBS solution containing 0.5% BSA and 0.1% Triton-X-100, resuspended in PBS solution containing 3% (wt/vol) BSA and 0.05% sodium azide, and incubated for 1 h at 25°C with 1,000 rpm shaking. Beads were washed thrice more with PBS solution, resuspended in PBS solution containing 0.5% BSA and 0.05% sodium azide, and stored at 4°C.
Beading from Human Blood. BT474, MCF-7 or 771.221 cells were harvested and washed with PBS solution containing 1% FCS, before resuspension at 10 6 cells per milliliter in PBS solution containing 1% FCS. Carboxyfluorescein succinimidyl ester (CFSE; Sigma-Aldrich) was added at a final concentration of 10 μM and incubated at 37°C in the dark for 15 min. Labeled cells were spun at 250 × g for 3 min, resuspended in DMEM with 10% (vol/vol) FCS, 50 U/mL penicillin, and 50 μg/mL streptomycin, and incubated at 37°C in the dark for a further 30 min. Cells were spun at 250 × g for 3 min and resuspended in DMEM with 1% FCS, 50 U/mL penicillin, and 50 μg/mL streptomycin (D1) containing protease inhibitors. Protease inhibitors, in each case, were a 1:100 dilution from a stock of one Complete mini EDTAfree protease inhibitor tablet (Roche) dissolved in 1.5 mL MilliQ water. A total of 250,000 cells were spiked into 1 mL of human blood obtained from a healthy donor. The protocol, including the use and handling of human blood, was approved by the University of Oxford Central University Research Ethics Committee.
Samples were transferred into red blood cell lysis buffer (154 mM NH 4 Cl, 10 mM KHCO 3 , 0.1 mM EDTA, pH 7.2, containing protease inhibitors) at the ratio of 25 mL lysis buffer per 1 mL blood and incubated at 25°C for 7 min. Cells were spun at 250 × g for 3 min, and the pellet was washed twice with 1 mL D1 containing protease inhibitors. Cells were incubated for 1 h at 25°C in 100 μL D1 with 250 μg/mL water-soluble cholesterol (Sigma-Aldrich) and protease inhibitors. Immunomagnetic isolation was performed by using KTag-AffiHER2b-SpyTag following the procedure described in Materials and Methods. Following isolation, samples were washed with 400 μL PBS solution and then fixed by resuspending cells in 100 μL PBS solution containing 4% (wt/vol) formaldehyde and incubating for 10 min at 25°C. Cells were washed once with 400 μL PBS solution and labeled with 100 μL per sample of 1:20 goat antihuman CD45-phycoerythrin (PE; Life Technologies) for 10 min at 25°C in the dark. Excess antibody was removed by placing samples on a magnet and washing cells with 200 μL PBS solution before resuspending in 30 μL PBS solution. As a positive control for CD45 staining, a human whole-blood sample was incubated with lysis buffer and washed as described earlier, but was fixed and stained without any magnetic isolation.
Microscopy. Cells were imaged in a hemocytometer using a 4× lens on an inverted DeltaVision wide-field fluorescence microscope (Applied Precision). Data in the FITC channel for CFSE (490DF20 excitation, 528DF38 emission, Chroma 84100bs polychroic), TRITC channel for PE (555DF28 excitation, 617DF73 emission, Chroma 84100bs polychroic) and bright-field images were collected and analyzed using softWoRx 3.6.2 software (Applied Precision). Background was corrected with the same software. Typical exposure times were 0.25-2 s. Different samples from the same experiment were prepared, imaged, and analyzed by using identical conditions. Flow Cytometry. Cells were harvested and resuspended at 2.5 × 10 6 cells per milliliter. A total of 125,000 cells per sample were incubated in PBS solution containing 1% BSA and 0.1% NaN 3 (FACS-A buffer) with or without 10 μg/mL mouse anti-human EGFR (Ab-1 clone 528; Millipore) for 10 min at 25°C. Antibody excess was removed by centrifugation. Samples were washed thrice with 100 μL FACS-A buffer. A total of 100 μL per sample of 1:100 goat anti-mouse IgG-PE (Life Technologies) in FACS-A buffer was added to samples, and cells were incubated for 10 min on ice. Cells were spun at 368 × g for 3 min at 4°C and washed thrice with 100 μL FACS-A buffer. Samples were resuspended in 300 μL FACS-A buffer on ice and analyzed on a FACScalibur flow cytometer with CellQuest Pro version 5.2.1 software (Becton Dickinson).
Statistical Analysis. Statistical tests were unpaired two-tailed t tests and were performed with GraphPad software QuickCalcs. S4 . Analysis of affibody polymers on beads. KTag-AffiEGFR-SpyTag (Affi) polymerized on magnetic beads. Samples were boiled with DTT and analyzed by SDS/PAGE with Coomassie staining. Monomer KTag-AffiEGFR-SpyTag and polymerized KTag-AffiEGFR-SpyTag were also analyzed in the absence of beads. The 66-kDa band corresponding in molecular weight to BSA was present in the initial bead preparation and was not removed by prolonged washing. Bands eluted from the beads are marked corresponding to Cys-SpyCatcher covalently linked to different numbers of affibodies (separated by ∼12 kDa). Fluorescence microscopy of cells recovered from blood, using beads coated with polymeric or monomeric affibody. CFSE (Top) marks the cell lines and anti-CD45 (Middle) the leukocytes also recovered. (Bottom) Overlay of CFSE (green), anti-CD45 (red), and bright-field (grayscale) images. The white blood cell sample (from whole blood, after red blood cell lysis but without magnetic separation) acted as a positive control for CD45 staining.
